Moreover, tumor formation by human ovarian cancer cells is enhanced by the exogenous expression of pro-HB-EGF, which is blocked by siRNAs for HB-EGF and CRM197, a nontoxic mutant of Dtx. Here, HBEGF is linked to ovarian cancer.